Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir vs Efavirenz in HIV-1 Naive Patients
NCT00005000Phase 4Unknown
- Sponsor
- Agouron Pharmaceuticals
- Start
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nelfinavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Agouron Pharmaceuticals. Status: unknown.
02
Drugs
nelfinavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00005000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005000.